RN7SL600P

Across TCGA pan-cancer cohorts, RN7SL600P RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RN7SL600P’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RN7SL600P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL600P is over-expressed in tumor, although a few such as LUAD and BRCA show the opposite, repressed pattern.

LUAD, BRCA, and BLCA are the cancer types where RN7SL600P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL600P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	II,III,IV	−1.067	<.001	8	view →
BRCA	All	III,IV	−0.961	<.001	8	view →
BLCA	Female	III,IV	−1.234	<.001	7	view →
LUSC	All	II,III,IV	−1.296	<.001	6	view →
KICH	All	All	−0.437	<.001	5	view →
THCA	Female	All	−0.467	<.001	4	view →
CHOL	All	All	+0.952	.003	2	view →
PAAD	All	All	+0.744	.030	2	view →
KIRC	All	All	+0.149	.027	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

RN7SL600P–LUAD

Open the LUAD breakdown →